|
|
||||||||
Subunit of Phosphoinositide 3-Kinase1


* Department of Molecular Biology and Biochemistry, University of California, Irvine, CA 92697;
Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, MA 02215; and
Division of Biology, California Institute of Technology, Pasadena, CA 91125
Phosphoinositide 3-kinase activation is important for lymphocyte proliferation and survival. Disrupting the gene that encodes the major phosphoinositide 3-kinase regulatory isoform p85
impairs B cell development and proliferation. However, T cell functions are intact in the absence of p85
. In this study, we test the hypothesis that the related isoform p85
is an essential regulatory subunit for T cell signaling. Unexpectedly, T cells lacking p85
showed a marked increase in proliferation and decreased death when stimulated with anti-CD3 plus IL-2. Both CD4+ and CD8+ T cells completed more cell divisions. Transcriptional profiling revealed reduced levels of caspase-6 mRNA in p85
-deficient T cells, which was paralleled by reduced caspase-6 enzyme activity. Increased T cell accumulation was also observed in vivo following infection of p85
-deficient mice with mouse hepatitis virus. Together, these results suggest a unique role for p85
in limiting T cell expansion.
This article has been cited by other articles:
![]() |
A. J. de Souza, J. S. Oak, R. Jordanhazy, R. H. DeKruyff, D. A. Fruman, and L. P. Kane T Cell Ig and Mucin Domain-1-Mediated T Cell Activation Requires Recruitment and Activation of Phosphoinositide 3-Kinase J. Immunol., May 15, 2008; 180(10): 6518 - 6526. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Munugalavadla, E. C. Sims, J. Borneo, R. J. Chan, and R. Kapur Genetic and pharmacologic evidence implicating the p85{alpha}, but not p85{beta}, regulatory subunit of PI3K and Rac2 GTPase in regulating oncogenic KIT-induced transformation in acute myeloid leukemia and systemic mastocytosis Blood, September 1, 2007; 110(5): 1612 - 1620. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Matheu, J. A. Deane, I. Parker, D. A. Fruman, and M. D. Cahalan Class IA Phosphoinositide 3-Kinase Modulates Basal Lymphocyte Motility in the Lymph Node J. Immunol., August 15, 2007; 179(4): 2261 - 2269. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Geering, P. R. Cutillas, G. Nock, S. I. Gharbi, and B. Vanhaesebroeck Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers PNAS, May 8, 2007; 104(19): 7809 - 7814. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Deane, M. G. Kharas, J. S. Oak, L. N. Stiles, J. Luo, T. I. Moore, H. Ji, C. Rommel, L. C. Cantley, T. E. Lane, et al. T-cell function is partially maintained in the absence of class IA phosphoinositide 3-kinase signaling Blood, April 1, 2007; 109(7): 2894 - 2902. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Shiroki, S. Matsuda, T. Doi, M. Fujiwara, Y. Mochizuki, T. Kadowaki, H. Suzuki, and S. Koyasu The p85{alpha} Regulatory Subunit of Class IA Phosphoinositide 3-Kinase Regulates beta-Selection in Thymocyte Development J. Immunol., February 1, 2007; 178(3): 1349 - 1356. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Oak, J. A. Deane, M. G. Kharas, J. Luo, T. E. Lane, L. C. Cantley, and D. A. Fruman Sjogren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase PNAS, November 7, 2006; 103(45): 16882 - 16887. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Okkenhaug, D. T. Patton, A. Bilancio, F. Garcon, W. C. Rowan, and B. Vanhaesebroeck The p110{delta} Isoform of Phosphoinositide 3-Kinase Controls Clonal Expansion and Differentiation of Th Cells J. Immunol., October 15, 2006; 177(8): 5122 - 5128. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Hale, D. Jackson, Y.-H. Chen, R. A. Lamb, and R. E. Randall Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling PNAS, September 19, 2006; 103(38): 14194 - 14199. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |